728 related articles for article (PubMed ID: 17845587)
41. Equally elevated concentrations of exhaled nitric oxide in nonatopic and low-sensitized atopic asthmatics.
Ekroos H; Rouhos A; Pallasaho P; Karjalainen J; Sarna S; Sovijärvi AR
Respir Med; 2009 Jan; 103(1):152-8. PubMed ID: 18951776
[TBL] [Abstract][Full Text] [Related]
42. The Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthma.
Silkoff PE; Carlson M; Bourke T; Katial R; Ogren E; Szefler SJ
J Allergy Clin Immunol; 2004 Nov; 114(5):1241-56. PubMed ID: 15536442
[TBL] [Abstract][Full Text] [Related]
43. The impact of ambient NO on online measurements of exhaled and nasal NO: the PIAMA study.
Gehring U; Oldenwening M; Brunekreef B; Wieringa MH; Kerkhof M; Smit HA; van der Ent CK; De Jongste JC
Pediatr Allergy Immunol; 2009 Nov; 20(7):665-72. PubMed ID: 19624453
[TBL] [Abstract][Full Text] [Related]
44. The value of FeNO measurement in asthma management: the motion against FeNO to help manage childhood asthma--reality bites.
Franklin PJ; Stick SM
Paediatr Respir Rev; 2008 Jun; 9(2):122-6. PubMed ID: 18513672
[TBL] [Abstract][Full Text] [Related]
45. The value of sputum 8-isoprostane in detecting oxidative stress in mild asthma.
Louhelainen N; Rytilä P; Obase Y; Mäkelä M; Haahtela T; Kinnula VL; Pelkonen A
J Asthma; 2008 Mar; 45(2):149-54. PubMed ID: 18350407
[TBL] [Abstract][Full Text] [Related]
46. Variability of FeNO in healthy subjects at 2240 meters above sea level.
Gochicoa-Rangel L; Rojas-Cisneros F; Miguel-Reyes JL; Guerrero-Zúñiga S; Mora-Romero U; Maldonado-Mortera AK; Torre-Bouscoulet L
J Clin Monit Comput; 2016 Aug; 30(4):445-9. PubMed ID: 26174797
[TBL] [Abstract][Full Text] [Related]
47. Reference values and determinants of exhaled nitric oxide in healthy Korean adults.
Kim SH; Kim TH; Sohn JW; Yoon HJ; Shin DH; Park SS
J Asthma; 2010 Jun; 47(5):563-7. PubMed ID: 20536283
[TBL] [Abstract][Full Text] [Related]
48. Is exhaled nitric oxide a useful adjunctive test for assessing asthma?
Bernstein JA; Davis B; Alvarez-Puebla MJ; Nguyen D; Levin L; Olaguibel JM
J Asthma; 2009 Nov; 46(9):955-60. PubMed ID: 19905926
[TBL] [Abstract][Full Text] [Related]
49. An economic evaluation of NIOX MINO airway inflammation monitor in the United Kingdom.
Price D; Berg J; Lindgren P
Allergy; 2009 Mar; 64(3):431-8. PubMed ID: 19183419
[TBL] [Abstract][Full Text] [Related]
50. Exhaled nitric oxide and respiratory symptoms in a community sample of school aged children.
Kovesi T; Dales R
Pediatr Pulmonol; 2008 Dec; 43(12):1198-205. PubMed ID: 19003883
[TBL] [Abstract][Full Text] [Related]
51. Single-breath exhaled nitric oxide in preschool children facilitated by a servo-controlled device maintaining constant flow.
Silkoff PE; Bates CA; Meiser JB; Bratton DL
Pediatr Pulmonol; 2004 Jun; 37(6):554-8. PubMed ID: 15114557
[TBL] [Abstract][Full Text] [Related]
52. Exhaled nitric oxide reflects asthma severity and asthma control.
Delgado-Corcoran C; Kissoon N; Murphy SP; Duckworth LJ
Pediatr Crit Care Med; 2004 Jan; 5(1):48-52. PubMed ID: 14697108
[TBL] [Abstract][Full Text] [Related]
53. [Reproducibility of exhaled nitric oxide (FENO) measurements in healthy subjects].
Kumor M; Przybyłowski T; Maskey-Warzechowska M; Hildebrand K; Fangrat A; Bielicki P; Górska K; Kościuch J; Kucińska J; Chazan R
Pneumonol Alergol Pol; 2004; 72(9-10):395-9. PubMed ID: 16021993
[TBL] [Abstract][Full Text] [Related]
54. [Measurement of fraction of exhaled nitric oxide with the portable NIOX-MINO monitor in healthy adults].
Fortuna AM; Feixas T; Casan P
Arch Bronconeumol; 2007 Mar; 43(3):176-9. PubMed ID: 17386196
[TBL] [Abstract][Full Text] [Related]
55. Exhaled nitric oxide in evaluation of young adults with chronic cough.
Kowal K; Bodzenta-Lukaszyk A; Zukowski S
J Asthma; 2009 Sep; 46(7):692-8. PubMed ID: 19728207
[TBL] [Abstract][Full Text] [Related]
56. Office-based exhaled nitric oxide measurement in children 4 years of age and older.
Hanson JR; De Lurgio SA; Williams DD; Dinakar C
Ann Allergy Asthma Immunol; 2013 Nov; 111(5):358-63. PubMed ID: 24125141
[TBL] [Abstract][Full Text] [Related]
57. Repeatability of standardised nasal nitric oxide measurements in healthy and asthmatic adults and children.
Kharitonov SA; Walker L; Barnes PJ
Respir Med; 2005 Sep; 99(9):1105-14. PubMed ID: 16085212
[TBL] [Abstract][Full Text] [Related]
58. Are exhaled nitric oxide measurements using the portable NIOX MINO repeatable?
Selby A; Clayton B; Grundy J; Pike K; Drew K; Raza A; Kurukulaaratchy R; Arshad SH; Roberts G
Respir Res; 2010 Apr; 11(1):43. PubMed ID: 20416092
[TBL] [Abstract][Full Text] [Related]
59. Validation study of asthma screening criteria based on subjective symptoms and fractional exhaled nitric oxide.
Fukuhara A; Saito J; Sato S; Sato Y; Nikaido T; Saito K; Fukuhara-Nakagawa N; Inokoshi Y; Ishii T; Tanino Y; Ishida T; Munakata M
Ann Allergy Asthma Immunol; 2011 Dec; 107(6):480-6. PubMed ID: 22123376
[TBL] [Abstract][Full Text] [Related]
60. New method for single-breath fraction of exhaled nitric oxide measurement with improved feasibility in preschool children with asthma.
Heijkenskjöld-Rentzhog C; Kalm-Stephens P; Nordvall L; Malinovschi A; Alving K
Pediatr Allergy Immunol; 2015 Nov; 26(7):662-7. PubMed ID: 26184580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
